236 related articles for article (PubMed ID: 1398926)
1. Experimental verocytotoxemia in rabbits.
Richardson SE; Rotman TA; Jay V; Smith CR; Becker LE; Petric M; Olivieri NF; Karmali MA
Infect Immun; 1992 Oct; 60(10):4154-67. PubMed ID: 1398926
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
3. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
4. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.
Zoja C; Corna D; Farina C; Sacchi G; Lingwood C; Doyle MP; Padhye VV; Abbate M; Remuzzi G
J Lab Clin Med; 1992 Aug; 120(2):229-38. PubMed ID: 1323633
[TBL] [Abstract][Full Text] [Related]
5. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid.
Ludwig K; Karmali MA; Smith CR; Petric M
Can J Microbiol; 2002 Jan; 48(1):99-103. PubMed ID: 11888169
[TBL] [Abstract][Full Text] [Related]
6. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.
Richardson SE; Karmali MA; Becker LE; Smith CR
Hum Pathol; 1988 Sep; 19(9):1102-8. PubMed ID: 3047052
[TBL] [Abstract][Full Text] [Related]
7. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.
Reymond D; Karmali MA; Clarke I; Winkler M; Petric M
J Clin Microbiol; 1997 Mar; 35(3):609-13. PubMed ID: 9041398
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in human renal proximal tubular epithelial cells by Escherichia coli verocytotoxin 1 in vitro.
Kodama T; Nagayama K; Yamada K; Ohba Y; Akeda Y; Honda T
Med Microbiol Immunol; 1999 Nov; 188(2):73-8. PubMed ID: 10753058
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.
Proulx F; Seidman EG; Karpman D
Pediatr Res; 2001 Aug; 50(2):163-71. PubMed ID: 11477199
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic uremic syndrome following hemorrhagic colitis caused by verotoxin-producing Escherichia coli O157:H7: early signs of hemolytic uremic syndrome.
Tsuji A; Sasaki M; Kanemitsu T; Uehara N; Ito H; Honda M
Keio J Med; 1996 Mar; 45(1):44-7. PubMed ID: 8882467
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species as a risk factor in verotoxin-1-exposed rats.
Matsunaga T; Nakajima T; Sonoda M; Kawai S; Kobayashi J; Inoue I; Satomi A; Katayama S; Hara A; Hokari S; Honda T; Komoda T
Biochem Biophys Res Commun; 1999 Jul; 260(3):813-9. PubMed ID: 10403847
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin-producing Escherichia coli serotype OX3:H21 as a cause of hemolytic-uremic syndrome.
Keskimäki M; Ikäheimo R; Kärkkäinen P; Scheutz F; Ratiner Y; Puohiniemi R; Siltonen A
Clin Infect Dis; 1997 Jun; 24(6):1278-9; discussion 1280-2. PubMed ID: 9195109
[No Abstract] [Full Text] [Related]
15. Demonstration of RNA N-glycosidase activity of a Vero toxin (VT2 variant) produced by Escherichia coli O91:H21 from a patient with the hemolytic uremic syndrome.
Furutani M; Ito K; Oku Y; Takeda Y; Igarashi K
Microbiol Immunol; 1990; 34(4):387-92. PubMed ID: 2194093
[TBL] [Abstract][Full Text] [Related]
16. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome.
Takeda T; Dohi S; Igarashi T; Yamanaka T; Yoshiya K; Kobayashi N
J Infect; 1993 Nov; 27(3):339-41. PubMed ID: 8308331
[No Abstract] [Full Text] [Related]
17. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system.
Mizuguchi M; Tanaka S; Fujii I; Tanizawa H; Suzuki Y; Igarashi T; Yamanaka T; Takeda T; Miwa M
Acta Neuropathol; 1996; 91(3):254-62. PubMed ID: 8834537
[TBL] [Abstract][Full Text] [Related]
18. [Isolation of verocytotoxin-producing Escherichia coli from cattle and pets].
Tanaka H; Kondo R; Nishiuchi C; Matsuda H; Kimura M; Memida K; Kikuchi M; Tsukamoto T; Yamasaki S; Lin Z
Kansenshogaku Zasshi; 1992 Apr; 66(4):448-55. PubMed ID: 1624837
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits.
Fujii J; Kinoshita Y; Yamada Y; Yutsudo T; Kita T; Takeda T; Yoshida S
Microb Pathog; 1998 Sep; 25(3):139-46. PubMed ID: 9790873
[TBL] [Abstract][Full Text] [Related]
20. Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium.
Bitzan MM; Wang Y; Lin J; Marsden PA
J Clin Invest; 1998 Jan; 101(2):372-82. PubMed ID: 9435309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
